Ledger.Open graph →
SEC Form D · filed December 29, 2022

Transposon Therapeutics, Inc

Offering
$20.0M
Sold
—
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
MENLO PARK, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Eckard R. Weber, Md · MENLO PARK, CAExec · DirectorJohn R. Pacifico · Menlo Park, CADirectorBrent R. Ahrens · MENLO PARK, CADirectorWilliam R. Harrington, Md, Mba · MENLO PARK, CADirectorKeith A. Katkin · PALO ALTO, CADirectorDaniel R. Hetu, Md, Mba · MENLO PARK, CADirectorBrian T. Slingsby, Md, Phd, Mph · MENLO PARK, CADirectorLynne R. Rollins · SAN DIEGO, CAExecEckard R. Weber, Md · MENLO PARK, CAExec · DirectorJohn R. Pacifico · Menlo Park, CADirectorBrent R. Ahrens · MENLO PARK, CADirectorWilliam R. Harrington, Md, Mba · MENLO PARK, CADirectorKeith A. Katkin · PALO ALTO, CADirectorLynne R. Rollins · SAN DIEGO, CAExecDaniel R. Hetu, Md, Mba · MENLO PARK, CADirectorBrian T. Slingsby, Md, Phd, Mph · MENLO PARK, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗